GALLANT-1: Galectin-3 (Gal-3) inhibitor, GB1211, plus atezolizumab (atz) in patients (pts) with non-small cell lung cancer (NSCLC) - a dose finding study followed by a randomised, double-blind, placebo-controlled trial

被引：1

作者：

Ghiringhelli, F. ^{[1
]}

Barre, P. ^{[2
]}

Pichon, E. ^{[3
]}

Aix, S. Ponce ^{[4
]}

Vidal, O. J. Juan ^{[5
]}

Costa, E. Carcereny ^{[6
]}

Sethi, T. ^{[7
]}

Lindmark, B. ^{[8
]}

MacKinnon, A. ^{[7
]}

Aslanis, V. ^{[9
]}

Phung, D. H. ^{[10
]}

Jensen, P. ^{[11
]}

Rajiwate, Z. ^{[12
]}

Ross, G. ^{[8
]}

Basse, L. ^{[8
]}

机构：

[1] Univ Burgundy, Genet & Immuno therapy Med Inst, Ctr Georges Francois Leclerc, Dijon, France

[2] Montpellier Reg Univ Hosp, Dept Thorac Oncol, Montpellier, France

[3] CHRU Bretonneau, Serv Pneumol, Tours, France

[4] Hosp Univ 12 Octubre, Dept Med Oncol, Madrid, Spain

[5] La Fe Univ Hosp, Dept Med Oncol, Valencia, Spain

[6] Germans Trias & Pujol Hosp, Catalan Inst Oncol Badalona, Dept Med Oncol, Barcelona, Spain

[7] Galecto Biotech AB, Pre Clin Res & Dev, Copenhagen, Denmark

[8] Galecto Biotech AB, Clin Res & Dev, Copenhagen, Denmark

[9] Galecto Biotech AB, Pharmacokinet, Copenhagen, Denmark

[10] Galecto Biotech AB, Biostat, Copenhagen, Denmark

[11] Galecto Biotech AB, Project Management, Copenhagen, Denmark

[12] Galecto Biotech AB, Clin Operat, Copenhagen, Denmark

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期

关键词：

D O I：

10.1016/j.annonc.2022.07.1315

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1192TiP

引用

页码：S1093 / S1094

页数：2

共 50 条

[1] GALLANT-1: Galectin-3 (Gal-3) inhibitor GB1211 plus atezolizumab (atezo) in patients with non-small cell lung cancer (NSCLC)-A randomized, double-blind trial.
Ghiringhelli, Francois
Doucet, Ludovic
Barre, Patricia
Pichon, Eric
Aix, Santiago Ponce
Juan-Vidal, Oscar
Carcereny, Enric
Sethi, Tariq
Lindmark, Bertil
MacKinnon, Alison
Aslanis, Vassilios
Rajiwate, Zahir
Basse, Linda
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[2] GALLANT-1: GB1211 galectin-3 (Gal-3) inhibitor plus atezolizumab (atz) for first line treatment in patients (pts) with advanced/metastatic non-small cell lung cancer (NSCLC)
Aparisi Aparisi, F. D. A.
Felip, E.
Pichon, E.
Carcereny, E.
Barre, P.
Raumlau, R.
Sethi, T.
Lindmark, B.
Slack, R.
MacKinnon, A.
Aslanis, V.
Phung, D.
Jensen, P.
Rajiwate, Z.
Ross, G.
Basse, L.
Ghiringhelli, F.
ANNALS OF ONCOLOGY, 2023, 34
[3] Vitamin D Supplementation and Survival of Patients with Non-small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
Akiba, Tadashi
Morikawa, Toshiaki
Odaka, Makoto
Nakada, Takeo
Kamiya, Noriki
Yamashita, Makoto
Yabe, Mitsuo
Inagaki, Takuya
Asano, Hisatoshi
Mori, Shohei
Tsukamoto, Yo
Urashima, Mitsuyoshi
CLINICAL CANCER RESEARCH, 2018, 24 (17) : 4089 - 4097
[4] Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
Nakagawa, Kazuhiko
Garon, Edward B.
Seto, Takashi
Nishio, Makoto
Aix, Santiago Ponce
Paz-Ares, Luis
Chiu, Chao-Hua
Park, Keunchil
Novello, Silvia
Nadal, Ernest
Imamura, Fumio
Yoh, Kiyotaka
Shih, Jin-Yuan
Au, Kwok Hung
Moro-Sibilot, Denis
Enatsu, Sotaro
Zimmermann, Annamaria
Frimodt-Moller, Bente
Visseren-Grul, Carla
Reck, Martin
LANCET ONCOLOGY, 2019, 20 (12): : 1655 - 1669
[5] CANOPY-A: A phase III, multicenter, randomized, double-blind, placebo-controlled trial evaluating canakinumab as adjuvant therapy in patients (pts) with completely resected non-small cell lung cancer (NSCLC).
Garon, Edward B.
Ardizzoni, Andrea
Barlesi, Fabrice
Cho, Byoung Chul
De Marchi, Pedro
Goto, Yasushi
Kowalski, Dariusz M.
Lu, Shun
Paz-Ares, Luis G.
Spigel, David R.
Spira, Alexander, I
Thomas, Michael
Leung, Mimi
Baum, Jason
Zhu, Zewen
Oliveira Portella, Maria do Socorro
Yang, James Chih-Hsin
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[6] Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
Reck, Martin
Kaiser, Rolf
Mellemgaard, Anders
Douillard, Jean-Yves
Orlov, Sergey
Krzakowski, Maciej
von Pawel, Joachim
Gottfried, Maya
Bondarenko, Igor
Liao, Meilin
Gann, Claudia-Nanette
Barrueco, Jose
Gaschler-Markefski, Birgit
Novello, Silvia
LANCET ONCOLOGY, 2014, 15 (02): : 143 - 155
[7] Randomized, double-blind, placebo-controlled, phase III multicentre study of paclitaxel plus carboplatin (TC) versus TC plus endostar in patients with advanced non-small cell lung cancer (NSCLC)
Han Baohui
Xiu Qingyu
Wang Huiming
Luo Yi
Bai Chunxue
Guo Shuliang
Liu Wenchao
Zhuang Zhixiang
Zhang Yang
Zhou Jianying
Jing Xianqiao
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S353 - S354
[8] ANALYSIS OF PATIENT-REPORTED OUTCOMES FROM THE LUME-LUNG 1 TRIAL: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY IN SECOND-LINE ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
Novello, Silvia
Mellemgaard, Anders
Kaiser, Rolf
Douillard, Jean-Yves
Orlov, Sergei
Krzakowski, Maciej
Von Pawel, Joachim
Gottfried, Maya
Bondarenko, Igor
Liao, Meilin
Barrueco, Jose
Gaschler-Markefski, Birgit
Griebsch, Ingolf
Reck, Martin
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1207 - S1207
[9] Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial
Miranda Gogishvili
Tamar Melkadze
Tamta Makharadze
Davit Giorgadze
Mikhail Dvorkin
Konstantin Penkov
Konstantin Laktionov
Gia Nemsadze
Marina Nechaeva
Irina Rozhkova
Ewa Kalinka
Christian Gessner
Brizio Moreno-Jaime
Rodolfo Passalacqua
Siyu Li
Kristina McGuire
Manika Kaul
Anne Paccaly
Ruben G. W. Quek
Bo Gao
Frank Seebach
David M. Weinreich
George D. Yancopoulos
Israel Lowy
Giuseppe Gullo
Petra Rietschel
Nature Medicine, 2022, 28 : 2374 - 2380
[10] Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial
Gogishvili, Miranda
Melkadze, Tamar
Makharadze, Tamta
Giorgadze, Davit
Dvorkin, Mikhail
Penkov, Konstantin
Laktionov, Konstantin
Nemsadze, Gia
Nechaeva, Marina
Rozhkova, Irina
Kalinka, Ewa
Gessner, Christian
Moreno-Jaime, Brizio
Passalacqua, Rodolfo
Li, Siyu
McGuire, Kristina
Kaul, Manika
Paccaly, Anne
Quek, Ruben G. W.
Gao, Bo
Seebach, Frank
Weinreich, David M.
Yancopoulos, George D.
Lowy, Israel
Gullo, Giuseppe
Rietschel, Petra
NATURE MEDICINE, 2022, 28 (11) : 2374 - +

← 1 2 3 4 5 →